📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions. (2022)

First Author: Osanlou R

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-055551

PubMed Identifier: 35788071

Publication URI: http://europepmc.org/abstract/MED/35788071

Type: Journal Article/Review

Volume: 12

Parent Publication: BMJ open

Issue: 7

ISSN: 2044-6055